Title:
NOVEL AMINOAROMATIC COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES COMPRISING SAME AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2022/103201
Kind Code:
A1
Abstract:
The present invention provides a novel aminoaromatic compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition that is for preventing or treating neurodegenerative diseases and comprises same as an active ingredient, and a health functional food composition for preventing or ameliorating neurodegenerative diseases.
Inventors:
LEE CHANG JUN (KR)
CHUN HEEJUNG (KR)
WON WOOJIN (KR)
PARK KI DUK (KR)
PARK JONG HYUN (KR)
PAE AE NIM (KR)
CHOI JI WON (KR)
LEE ELIJAH (KR)
PARK SUN JUN (KR)
KIM HYEON JEONG (KR)
KIM YOOWON (KR)
KIM BYUNG EUN (KR)
KIM SIWON (KR)
CHUN HEEJUNG (KR)
WON WOOJIN (KR)
PARK KI DUK (KR)
PARK JONG HYUN (KR)
PAE AE NIM (KR)
CHOI JI WON (KR)
LEE ELIJAH (KR)
PARK SUN JUN (KR)
KIM HYEON JEONG (KR)
KIM YOOWON (KR)
KIM BYUNG EUN (KR)
KIM SIWON (KR)
Application Number:
PCT/KR2021/016542
Publication Date:
May 19, 2022
Filing Date:
November 12, 2021
Export Citation:
Assignee:
INST BASIC SCIENCE (KR)
KOREA INST SCI & TECH (KR)
KOREA INST SCI & TECH (KR)
International Classes:
C07C211/53; A23L29/00; A23L33/10; A61K31/136; A61P25/28
Foreign References:
| US20170001949A1 | 2017-01-05 | |||
| US20170037008A1 | 2017-02-09 | |||
| US20040192693A1 | 2004-09-30 |
Other References:
DATABASE REGISTRY 27 December 2013 (2013-12-27), ANONYMOUS: "1,4-Benzenediamine, N4-[2-(4-chlorophenyl)ethyl]-N1,N1-dimethyl- (CA INDEX NAME)", XP055930243, retrieved from STN Database accession no. 1505016-07-8
DATABASE REGISTRY 17 January 2014 (2014-01-17), ANONYMOUS: "1,4-Benzenediamine, N1-[3-(2-chlorophenyl)propyl]-N4,N4-diethyl-2-methyl- (CA INDEX NAME)", XP055930248, retrieved from STN Database accession no. 1523189-59-4
DONALD J. ABRAHAMED.: "Burger's Medicinal Chemistry and Drug Discovery", 2001, WILEY
"Design and Application of Prodrugs", 1985, HARWOOD ACADEMIC PUBLISHERS GMFH
NATURE NEUROSCIENCE, vol. 23, 2020, pages 1555 - 1566
J MED CHEM, vol. 44, no. 6, 15 March 2001 (2001-03-15), pages 923 - 30
DATABASE REGISTRY 17 January 2014 (2014-01-17), ANONYMOUS: "1,4-Benzenediamine, N1-[3-(2-chlorophenyl)propyl]-N4,N4-diethyl-2-methyl- (CA INDEX NAME)", XP055930248, retrieved from STN Database accession no. 1523189-59-4
DONALD J. ABRAHAMED.: "Burger's Medicinal Chemistry and Drug Discovery", 2001, WILEY
"Design and Application of Prodrugs", 1985, HARWOOD ACADEMIC PUBLISHERS GMFH
NATURE NEUROSCIENCE, vol. 23, 2020, pages 1555 - 1566
J MED CHEM, vol. 44, no. 6, 15 March 2001 (2001-03-15), pages 923 - 30
Attorney, Agent or Firm:
PLUS INTERNATIONAL IP LAW FIRM (KR)
Download PDF:
Previous Patent: LIGHT-EMITTING MODULE, METHOD FOR MANUFACTURING SAME AND DISPLAY DEVICE COMPRISING SAME
Next Patent: MOTOR
Next Patent: MOTOR